Visual analysis of tissue and cellular imaging is critical to defining and understanding stroke mechanisms. Ace Therapeutics offers a range of histological stains and specialty stains to help our customers achieve optimal staining results. Our range of staining products and supporting protocols are widely used in stroke research to help researchers better understand the structure and function of the nervous system and advance stroke science. Additionally, we provides antifade fluorescence mounting media range of products to help you acquire the quality of images and minimal signal intensity loss during research.
Tag: IHC and Histological Stains, Fluorescence Probes, Ion Indicators, Proteins and Antibodies Labeling, Antifades & Mounting Media
For more detailed staining protocols, please access a specific product or contact our scientists.
| Cat.# | Name | Size | Description | Price |
|---|---|---|---|---|
| ASSD-116 | Annexin V-FITC Apoptosis Staining / Detection Kit (AC116) | 1 kit, 100 tests |
Annexin V-FITC Apoptosis Staining / Detection Kit is a one-step staining procedure that detects apoptosis by staining exposed phosphatidylserine (PS) which has translocated to the external cell surface. The kit is used to detect membrane changes that occur in early apoptotic cells.
This kit contains:
• Annexin V-FITC Staining solution
• Propidium Iodide Staining solution
• 10x binding buffer
|
inquiry |
| ASSD-117 | Annexin V-PE Apoptosis Staining / Detection Kit (AC117) | 1 kit, 100 tests |
Annexin V-PE Apoptosis Staining/Detection Kit is a one-step staining procedure that detects apoptosis by staining exposed phosphatidylserine (PS) which has translocated to the external cell surface. The kit is used to detect membrane changes that occur in early apoptotic cells.
This kit contains:
• Annexin V-PE Staining solution
• 7-AAD Staining solution
• 10x binding buffer
|
inquiry |
| ASSD-118 | BrdU (5-Bromo-2′-deoxyuridine) (AC118) | 200 mg, 100 mg, 1 g, 5g |
BrdU is used to identify proliferating cells. It can Label cell lines and primary cell cultures in vitro and also cells in vivo.
It is widely used to study adult neurogenesis and can be used in combination with neuron specific markers such as NeuN to identify newly formed neurons. Additionally, it also frequently is used to label and fate-map dividing cells in neural stem cell biology.
Suitable for in vivo use.
|
inquiry |
| ASSD-119 | Fluorescent adenosine agonist [NECA] (AC119) | 500 μg |
A fluorescent adenosine receptor ligand derived from NECA, non-selective adenosine agonist. Fluorescent adenosine receptor agonist (pEC50 values are 8.57, 8.47, 6.76 and 5.69 for A3, A1, A2A and A2B respectively).
|
inquiry |
| ASSD-120 | Fluorescent adenosine antagonist [XAC] (AC120) | 500 μg |
Competitive fluorescent adenosine receptor antagonist (apparent KD values are 7.50, 7.37 and 7.30 for A2A, A3 and A1 respectively). Antagonizes the activity of NECA, an adenosine receptor agonist. Inhibits cAMP accumulation and stimulates inositol phosphate accumulation (pKb values are 6.4 and 6.5 respectively). Exhibits no intrinsic agonist activity.
|
inquiry |
| ASSD-121 | Fluorescent adenosine A3 antagonist [XAC] (AC121) | 500 μg |
Fluorescent A3 adenosine receptor antagonist. Displays selectivity for A3 over A2A and A1 (apparent KD values are 8.10, 6.74 and 6.57 respectively). Antagonizes the activity of NECA, an adenosine receptor agonist. Exhibits no intrinsic agonist activity. A fluorescent Xanthine Amine Congener (XAC) analog.
|
inquiry |
| ASSD-122 | Fluorescent β2 antagonist [(±)-propranolol] (AC122) | 500 μg |
Fluorescent adrenoceptor β2 antagonist (apparent KD values are 8.87, 7.25 and 6.98 for β2, β1 and β3 respectively). Antagonizes the activity of isoprenaline, a non-selective β-adrenoceptor agonist.
|
inquiry |
| ASSD-123 | Fluorescent β2 antagonist [(S)-propranolol-red] (AC123) | 500 μg |
Competitive fluorescent β2-adrenoceptor antagonist. Displays selectivity for β2 over β1 and β3 (apparent KD values are 9.21, 7.76 and 7.09 respectively). Antagonizes the activity of isoprenaline, a non-selective β-adrenoceptor agonist. Exhibits no intrinsic agonist activity.
|
inquiry |
| ASSD-124 | Fluorescent β2 antagonist [(S)-propranolol-green] (AC124) | 500 μg |
Fluorescent β2-adrenoceptor antagonist (apparent KD values are 7.68, 6.42 and <4.0 for β2, β1 and β3 respectively). Antagonizes the activity of isoprenaline, a non-selective β-adrenoceptor agonist. Exhibits no intrinsic agonist activity.
|
inquiry |
| ASSD-125 | Fluorescent D1 antagonist [SKF83566-green] (AC125) | 50 μg |
Selective fluorescent D1 dopamine receptor antagonist (apparent KD values are 7.09, < 5 and 7.56 for D1, D2 and D5 receptors respectively). Also antagonizes the activity of SKF 83566, a D1 dopamine receptor agonist. Displays no intrinsic agonist activity.
|
inquiry |
| ASSD-126 | Fluorescent H2 antagonist [aminopotentidine] (AC126) | 50 μg |
Fluorescent H2 histamine receptor antagonist (apparent KD values are 8.94, 7.3 and >6 for H2, H3 and H1 receptors respectively). Also antagonizes the activity of Histamine, a H1 agonist. Displays no intrinsic activity.
|
inquiry |
| ASSD-127 | Fluorescent H3 antagonist [clobenpropit] (AC127) | 50 μg |
Fluorescent H3 histamine receptor antagonist (apparent KD values are 7.09, 6.55 and 5.71 for H3, H1 and H2 receptors respectively). Also antagonizes the activity of Histamine, a H1 agonist. Displays no intrinsic activity.
|
inquiry |
| ASSD-128 | Fluorescent M3 antagonist [pirenzepine] (AC128) | 50 μg |
Fluorescent M3 muscarinic receptor antagonist (apparent KD values are 7.97, 6.29 and 6.24 for M3, M5 and M1 receptors respectively). Antagonizes the activity of carbachol, a muscarinic receptor agonist. Displays no intrinsic activity.
|
inquiry |
| ASSD-129 | Fluorescent 5-HT1A antagonist [NAN-190] (AC129) | 50 μg |
Fluorescent 5-HT1A serotonin receptor antagonist (apparent KD values are 8.75, 6.34 and 5.57 for 5-HT1A, 5-HT2A and 5-HT1B receptors respectively). Antagonizes the activity of serotonin, a 5-HT1A agonist.
|
inquiry |
| ASSD-130 | Calcein-AM (AC130) | 1 mg |
Non- fluorescent and cell permeable dye. Hydrolysed into green fluorescent calcein by cytosolic esterases in living cells.
|
inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.